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Background
Noninvasive ventilation (NIV) (continuous positive airway pressure [CPAP] or noninvasive intermittent positive-
pressure ventilation [NIPPV]) appears to be of benefi  t in the immediate treatment of patients with acute cardiogenic 
pulmonary edema and may reduce mortality.
Methods
Objective: To determine whether noninvasive ventilation reduces mortality and whether there are important 
diff  erences in outcome associated with the method of treatment (CPAP or NIPPV).
Design: Open, prospective, randomized controlled trial.
Setting: 26 emergency departments in hospital in the UK between July 2003 and April 2007.
Subjects: 1069 patients age >16 years with a clinical diagnosis of acute cardiogenic pulmonary edema, as determined 
by chest radiograph, respiratory rate >20 breaths/min, and arterial pH<7.35. Exclusion criteria included a requirement 
for a lifesaving or emergency intervention, inability to give consent, or previous recruitment in the trial.
Intervention: All patients received standard concomitant therapy. Patients were randomly assigned to standard 
oxygen therapy (up to 15 liters per minute via face mask), CPAP (5 to 15 cm of water), or NIPPV (inspiratory pressure, 
8 to 20 cm of water; expiratory pressure, 4 to 10 cm of water).
Outcomes: The primary end point for the comparison between noninvasive ventilation and standard oxygen therapy 
was death within 7 days after the initiation of treatment, and the primary end point for the comparison between 
NIPPV and CPAP was death or intubation within 7 days.
Results
A total of 1069 patients (mean [±SD] age, 77.7±9.7 years; female sex, 56.9%) were assigned to standard oxygen 
therapy (367 patients), CPAP (346 patients), or NIPPV (356 patients). There was no signifi  cant diff  erence in 7-day 
mortality between patients receiving standard oxygen therapy (9.8%) and those undergoing noninvasive ventilation 
(9.5%, P=0.87). There was no signifi  cant diff  erence in the combined end point of death or intubation within 7 days 
between the two groups of patients undergoing noninvasive ventilation (11.7% for CPAP and 11.1% for NIPPV, 
P=0.81). As compared with standard oxygen therapy, noninvasive ventilation was associated with greater mean 
improvements at 1 hour after the beginning of treatment in patient-reported dyspnea (treatment diff  erence, 0.7 on 
a visual-analogue scale ranging from 1 to 10; 95% confi  dence interval [CI], 0.2 to 1.3; P=0.008), heart rate (treatment 
diff  erence, 4 beats per minute; 95% CI, 1 to 6; P=0.004), acidosis (treatment diff  erence, pH 0.03; 95% CI, 0.02 to 0.04; 
P<0.001), and hypercapnia (treatment diff  erence, 0.7 kPa [5.2 mm Hg]; 95% CI, 0.4 to 0.9; P<0.001). There were no 
treatment-related adverse events.
Conclusion
In patients with acute cardiogenic pulmonary edema, noninvasive ventilation induces a more rapid improvement in respiratory 
distress and metabolic disturbance than does standard oxygen therapy but has no eff  ect on short-term mortality.
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Acute cardiogenic pulmonary edema (ACPE) is common, 
costly, and lethal, with associated mortality rates of 10-
20% [2,3]. When severe, it is traditionally managed with 
endotracheal intubation and mechanical ventilation. 
Interest in using noninvasive ventilation (NIV) in the 
treatment of ACPE has grown since the early work of 
Rasanen and colleagues from 1985 [4]. Whether delivered 
in the form of continuous positive airway pressure 
(CPAP) or noninvasive intermittent positive pressure 
ventilation (NIPPV), NIV improves physiologic para-
meters in patients with ACPE, including decreasing 
respiratory acidosis, respiratory rate, work of breathing, 
heart rate, and sensation of dyspnea [5,6]. It may also 
reduce rates of endotracheal intubation [5,7,8]. A variety 
of clinical trials have been conducted in this area, though 
most were small, single-centered studies lacking power to 
determine if NIV reduces mortality [4,9-18]. Recent 
systematic reviews and meta-analyses suggest that indeed 
it may [5-8]. However, the small size of included studies 
and variation in study populations, interventions, and 
endpoints leave some doubt to the generalizability of 
these ﬁ  ndings.
To address these uncertainties, Gray and colleagues 
performed a large, multi-center, randomized controlled 
trial in 1069 patients with ACPE to determine whether 
NIV improves survival and if NIPPV is superior to CPAP 
[1]. Th  eir trial, referred to as the 3CPO (Th  ree inter-
ventions in Cardiogenic Pulmonary Oedema) study, was 
completed in 26 emergency departments in the UK. 
Patients were randomized to three groups: standard 
oxygen therapy, CPAP (5 – 15 cm of H2O), or NIPPV (8/4 
to 20/10 cm of H2O). Th   ere were no diﬀ  erences in base-
line characteristics, comorbid conditions, or the receipt 
of standard medical treatments, such as diuretics, 
nitrates and opiates. Th   ough NIV did provide more rapid 
improvement in respiratory distress and metabolic 
distur    bances, there were no diﬀ   erences in clinical 
outcomes, including mortality, rates of endotracheal 
intubation, length of stay, or myocardial infarction. Th  ere 
were no diﬀ  erences between CPAP and NIPPV in any of 
the primary or secondary outcomes. Th  e  authors 
conclude that in patients with ACPE, noninvasive 
ventilation produces more rapid resolution of metabolic 
abnormalities and respiratory distress but has no eﬀ  ect 
on short-term mortality.
Th   is study has a number of strengths, most important 
of which is that it was the largest randomized trial to date 
in this area, enrolling more patients than the combined 
number of patients from all studies included in prior 
meta-analyses [5-8]. Some limitations deserve mention. 
Th   is was a study of patients presenting to the emergency 
department and therefore may not apply to the use of 
NIV in the pre-hospital setting or to those patients who 
develop ACPE later in their hospital stay. Patients were 
excluded if they required lifesaving or emergency inter-
vention, a group that might have beneﬁ  ted most from 
NIV. Th  e most concerning limitation, however, is the 
considerable cross-over between groups and the lack of 
objective criteria for intubation. Fifty-six patients who 
failed standard oxygen treatment were rescued with NIV. 
Assuming that all 56 would have required intubation, the 
control 7-day intubation rate would have increased from 
2.8% to 18.0%, which would have made the intubation 
rate in the standard oxygen treatment group signiﬁ  cantly 
greater than the NIV group (2.9%).
Recommendation
Th   e results of this study should not limit the use of NIV 
in the setting of ACPE. NIV leads to more rapid improve-
ment of symptoms of respiratory distress and metabolic 
disturbances as compared to standard oxygen therapy. 
We further argue that based on this study, one should not 
draw a conclusion that NIV is ineﬀ  ective in preventing 
intubation. Th   ough NIV has not been convincingly shown 
to reduce mortality, it remains a valuable adjunct in the 
treatment of ACPE.
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